510(k) K252280
K252280 is an FDA 510(k) premarket notification submitted by Roche Diagnostics for the device "Elecsys Anti-SARS-CoV-2 S". The FDA issued a decision of Substantially Equivalent on Apr 13, 2026. The device falls under product code QVP (Sars-Cov-2 Serology Test), a Class II device regulated under 21 CFR 866.3983. Roche Diagnostics has 456 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Apr 13, 2026
- Date Received
- Jul 22, 2025
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Sars-Cov-2 Serology Test
- Device Class
- Class II
- Regulation Number
- 866.3983
- Review Panel
- MI
- Submission Type
- 510(k)
A SARS-CoV-2 serology test is a prescription in vitro diagnostic device for the detection of specific binding antibodies to SARS-CoV-2 in clinical specimens. The detection of SARS-CoV-2 antibodies is intended to aid in identifying individuals with an adaptive immune response to SARS-CoV-2. The test is not intended for the diagnosis of acute SARS-CoV-2 infection, nor screening blood, plasma, cells, or tissue donors.
Need the full FDA record for Roche Diagnostics? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.